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Reduced immune functioning may have a negative impact on sleep and health, and vice versa. A survey among Dutch young
adults (18–35 years old) was administered to collect information on perception of reduced immunity and its relationship to sleep
disorders, sleep duration, and quality. Sleep disorders were assessed with the SLEEP-50 questionnaire subscales of sleep apnea,
insomnia, circadian rhythm disorder, and daily functioning. Dutch young adults (N = 574) completed the survey. Among them,
subjects (N = 209; 36.4%) reported perceived reduced immunity. Relative to those with a normal immune status, subjects reporting
reduced immunity had significantly higher scores (𝑝 = 0.0001) on sleep apnea (2.6 versus 3.6), insomnia (5.1 versus 6.8), and
circadian rhythm disorder (2.1 versus 2.7). Subjects reporting reduced immunity also had significantly poorer daily functioning
scores (5.4 versus 7.6, 𝑝 = 0.0001). No differences were observed in total sleep time, but those reporting reduced immunity had
significantly poorer ratings of sleep quality (6.8 versus 7.2, 𝑝 = 0.0001). Our findings suggest that perceived reduced immunity
is associated with sleep disturbances, impaired daily functioning, and a poorer sleep quality. Experimental studies including the
assessment of immune biomarkers and objective measures of sleep (polysomnography) should confirm the current observations.
1. Introduction
Abidirectional relationship has been suggested between sleep
and immune functioning [1]. Sleep and a well-functioning
balanced immune system are both essential to maintain a
normal health status. Research has shown that reduced total
sleep time or sleep quality is related to reduced immune
functioning and thus increases susceptibility to disease [2, 3].
Conversely, sleep quality and total sleep time are impaired
during infection [4]. Sleep loss has a significant impact
on quality of life and poor sleep quality is related to a
variety of diseases [5], has a significant impact on total
health care costs, and is a major cause of work absenteeism
[6]. Correspondingly, sufficient sleep time is associated with
better immune functioning and positive health outcomes
[3, 7, 8].
Results from several studies, including objective mea-
surements such as actigraphy or determining biomarkers of
immune functioning, support the existence of the bidirec-
tional relationship between sleep and immune functioning.
For example, Orzech et al. demonstrated the relationship
between sleep, immune functioning, and susceptibility to
disease [9]. They evaluated sleep in (𝑁 = 56) adolescents
via actigraphy and assessed health status with weekly inter-
views. The authors found that a shorter total sleep time was
associated with more frequently experiencing acute illnesses
such as common cold, flu, gastroenteritis, and other common
infectious diseases that are a result of reduced immune
functioning. Similarly, Cohen et al. described that lower sleep
efficiency and shorter sleep duration in the weeks before
exposure to a rhinovirus are associated with lower immune
resistance and an almost three times increased risk to develop
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a common cold [2]. In line, Drake et al. showed that having a
common cold has detrimental effects on sleep, psychomotor
performance, and daytime alertness [10]. Although common
cold seems a relative harmless medical condition, it is the
most common complaint in general practice [11, 12], with
an underestimated economic impact in terms of absenteeism
and reduced work productivity [6].
Several studies have investigated the relationship between
sleep loss and immune functioning [7, 13–17]. These studies
revealed that sleep loss and poor sleep quality are associated
with dysregulation of immune functioning. For example,
sleep loss has been related to increases of proinflammatory
cytokines and reduced natural killer cell activity [18]. Proin-
flammatory cytokines interleukin- (IL-) 1, IL-6, and tumor
necrosis factor-𝛼 (TNF-𝛼) are involved in regulating both
sleep and immune function [19–22]. For example, in healthy
men, Dimitrov et al. [22] demonstrated a significant decrease
in TNF-𝛼 concentrations during sleep when compared to
being awake at night, and Ruiz et al. [23] found an increase in
leukocytes, neutrophils, and cluster of differentiation (CD4+)
concentrations during 2 nights of total sleep deprivation.
However, other studies did not report changes in IL-1𝛽, IL-6,
and TNF-𝛼 in relation to sleep and sleep deprivation [24–26].
Whereas the majority of studies focused on the rela-
tionship between immune functioning and sleep quality and
total sleep time [21], several other studies examined immune
functioning in patients with sleep apnea. A recent meta-
analysis of 51 studies identified several inflammatorymarkers
that are common in patients with sleep apnea, including
elevated serum concentrations of C-Reactive Protein, TNF-𝛼,
IL-6, IL-8, intercellular adhesion molecule (ICAM), vascular
cell adhesion molecule (VCAM), and selectins [27]. Effective
treatment of sleep apnea with continuous positive airway
pressure has been shown to decrease the elevated IL-6 serum
concentrations [28]. The presence and severity of other sleep
disorders remain understudied in relation to immunocom-
petence. In patients with insomnia, elevated levels of C-
Reactive Protein were found, which are also present during
inflammation [29, 30]. Irwin et al. described increased levels
of C-Reactive Protein in patients suffering from insomnia,
which reduced to normal levels after effective treatment
[31], whereas Savard et al. observed reduced numbers of
lymphocyte subpopulations (i.e., CD3+, CD4+, and CD8+
cells) in chronic insomniacs [32].These examples all illustrate
objective immune alterations in people suffering from insom-
nia.
It can be questioned however whether patients are aware
of these objective immune alterations and to what extent
they have an impact on related health behavior. Although
it is extremely important to have objective assessments of
immune functioning, people are often judging their health
status based on their perceived immune status (i.e., feelings
of reduced resistance). Similarly, although sleep may be
objectively disturbed, people only visit their physician if it
is experienced as such. It is based on this subjective health
status that people judge whether or not to visit their physician
and decide if they are capable of going to work or should
call in sick. Hence, it can be argued that the subjective
health experience is a critical determinant of people’s choices
regarding absenteeism and making use of the healthcare
system. Up to now, data relating perceived immune status to
sleep quality and duration is scarce. Therefore, the aim of the
current study is to explore the relationship between perceived
immunocompetence, sleep disorders, and daily functioning.
More specifically, it is investigatedwhether perceived reduced
immune functioning reduces sleep quality and total sleep
time, results in higher severity scores on sleep disorder scales
for insomnia, apnea, and circadian rhythm disorder (CRD),
and has a negative impact on daily functioning.
2. Methods
A survey among Dutch young adults (18–35 years old) on
immunity, sleep disorders, daily functioning, sleep duration,
and quality was administered. Most of the participants were
recruited at the campus of Utrecht University, Netherlands.
Informed consent was obtained before starting the survey
either in person or online through http://thesistools.com/.
Demographic data including age, gender, height, and weight
were collected. Participants indicated whether they were
experiencing reduced immunity or perceived a normal health
status in the past four weeks. To examine the presence
and severity of subjective sleep complaints over the past
four weeks, four of the nine subscales (26 items) of the
Dutch SLEEP-50 questionnairewere completed [33].The four
subscales include sleep apnea (eight items), insomnia (nine
items), CRD (three items), and impact of sleep complaints
on daytime functioning (six items). Because sleep disorders
can have a profound impact on daily functioning, the cor-
responding subscale was included as well. Each question
was scored on a 4-point scale: 1 (not at all), 2 (somewhat),
3 (rather much), and 4 (very much). Cut-off values for a
positive screen for sleep disorders include ≥15 on sleep apnea
items (sensitivity = 85%, specificity = 88%), ≥19 on insomnia
items (sensitivity = 71%, specificity = 75%), ≥8 on CRD
items (sensitivity = 83%, specificity = 69%), and ≥15 on
daily functioning (sensitivity = 84%, specificity = 77%) [33].
In addition to the SLEEP-50 questionnaire subscales, prior
night’s total sleep time was recorded, and an overall sleep
quality score ranging from 0 (very poor) to 10 (very good)
was obtained.
Statistical analyses were conducted using the Statistical
Package for the Social Sciences (SPSS) version 20 (IBM SPSS
Statistics).Mean and standard deviation (SD) were computed
for each variable and it was determined if scores were nor-
mally distributed. SLEEP-50 subscale scores, sleep duration,
and quality of subjects who reported reduced immunity were
compared to those who reported a normal health status.
As the SLEEP-50 data were not normally distributed, the
Independent Samples Mann-Whitney 𝑈 Test was used for
the statistical analyses. Results were considered significant if
𝑝 < 0.05.
3. Results
𝑁 = 574 Subjects (𝑁 = 574) completed the survey.
Their mean age was 22.3 years old and 68.5% of the sample
was women. Perceived reduced immunity was reported by
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Figure 1: Mean (SE) scores of subjects with perceived normal
health status (white bars) or perceived reduced immune functioning
(black bars) on sleep disorders, sleep quality, and daily functioning.
Significant differences (𝑝 < 0.05) are indicated by an asterisk.
subjects (𝑁 = 209; 36.4%). Subjects with perceived reduced
immunity were significantly older (22.5 versus 21.9 years old,
𝑝 = 0.024), smoked significantly more cigarettes per day (1.8
versus 0.7 cigarettes, 𝑝 = 0.001), and consumed significantly
more alcohol per week (10.5 versus 8.1 drinks, 𝑝 = 0.009)
when compared to subjects who reported a normal health
status. Subjects (𝑁 = 13; 2.2%) were screened positive for
having a sleep disorder.
Significant differences in SLEEP-50 scale scores were
found between subjects who reported a normal health status
and those reporting reduced immunity (see Figure 1).
Subjects reporting reduced immunity scored significantly
higher (𝑝 = 0.0001) on the subscales of sleep apnea (2.6
versus 3.6), insomnia (5.1 versus 6.8), and circadian rhythm
disorder (2.1 versus 2.7). Subjects reporting reduced immu-
nity also reported significantly poorer daily functioning
related to their sleep difficulties (5.4 versus 7.6, 𝑝 = 0.0001).
No significant differences were observed in total sleep time
(𝑝 = 0.733), but those reporting reduced immunity had
a significantly poorer rating of sleep quality (6.8 versus 7.2,
𝑝 = 0.0001).
4. Discussion
This study confirmed an association between sleep and
perceived immune functioning. Although no effects on
total sleep time were observed, in line with previous stud-
ies subjects with a perceived reduced immunocompetence
reported poorer sleep quality. In addition, these subjects
scored significantly higher on SLEEP-50 subscales screening
for sleep apnea, insomnia, and circadian rhythm disorders.
These findings were reflected in significantly poorer scores
on daily functioning in those reporting reduced immune
functioning.
The importance of the relationship between sleep and
immune functioning should not be underestimated. Poten-
tially, if patients with insomnia are effectively treated this
would reduce their susceptibility for immune-related dis-
eases and improve daytime functioning. Conversely, immune
status is likely to improve by improving overall sleep. In
this context, research has shown that increasing sleep time
reduces the susceptibility to disease per se [34]. Enforced by
the demands of our 24 h society, the average duration of a
normal night of sleep (seven to eight hours) has been reduced
by up to twohours per day over the past 35 years [35, 36].Over
the same time period, a significant increase in prevalence
rates of immune-related diseases has been reported [37],
which makes it tempting to link both developments to
each other. However, many other factors are postulated for
the increase in incidence and severity of immune-related
disorders such as dietary changes, life style changes, hygiene
hypotheses, and microbiome diversity. The corresponding
impact on quality of life and health care demands is evident
[5].
Several limitations of this pilot study need to be
addressed. First, the study was conducted only among young
adults. As this is a relative healthy segment of the population,
SLEEP-50 scores of the vast majority of these participants
did not reach the cut-off scores to be screened positive for
sleep apnea, insomnia, and circadian rhythm disorder. It
can be questioned if this sample of convenience is repre-
sentative for the general population. Generally individuals
in this group sleep less and have a lower prevalence of
sleep disorders. Results may be different for groups of
different age and socioeconomic status. Second, it should be
realized that the SLEEP-50 is a screening instrument and is
not meant to formally diagnose sleep disorders. Including
polysomnography in these studies would further extend our
knowledge. Future research should therefore replicate our
findings including a formal diagnosis of sleep disorders.
Third, immune status was assessed by a single item question
that could be answered by yes or no. It would have been
more informative to use questions providing more details
on the nature of perceived immune status. Then one could
differentiate between subjects with various severity levels
of reduced immunocompetence and further explore their
relationship with sleep by correlating these severity scores
with scores on the SLEEP-50 subscales. Finally, no immune
biomarkers were assessed in this study to objectively confirm
the reported perceived immune status. While all of these
limitations are important they all would result in decreased
sensitivity to changes in both sleep and immune function.
Despite this lack of sensitivity a significant relationship was
found between sleep and immune function.
5. Conclusions
This study showed that subjects who perceive reduced
immune functioning have significant higher scores on scales
assessing sleep apnea, insomnia, and CRD. They also report
significantly poorer sleep quality and have significant lower
scores on daytime functioning. Future studies with formal
diagnosis of sleep disorders and assessment of immune
biomarkers should confirm these findings.
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